Molecular Diagnostics

Fecal Immunochemical Tubes Sourced to Analyze Gut Microbiome for CRC
Colorectal cancer (CRC) is a challenging public health problem which successful treatment depends on the stage at diagnosis. Recently, CRC-specific microbiome signatures have been proposed as a marker for CRC detection. More...14 Oct 2021

First-of-Its-Kind Testing Device Allows For Rapid Detection of Bacteria That Identify Risk for Preterm Birth
A newly-developed cost-effective device can rapidly and accurately detect changes in vaginal bacteria and corresponding immune responses in pregnant women, which are associated with increased risk of preterm birth. More...14 Oct 2021

Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of lymphoid tumors and encompass peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), and several other entities of T-cell lymphoma. More...13 Oct 2021

Unique Gene Detects Mycobacterium Tuberculosis in Clinical Sputum
Tuberculosis (TB) is a common infectious disease caused by Mycobacterium tuberculosis (MTB). The main organ infected by MTB is the lung, but many other tissues or organs can be affected, such as the bone and pleura. Two million people die of MTB infection each year due to poor quality of life and lack of awareness. More...13 Oct 2021

Whole-Genome Sequencing Applied to Acutely Ill Infants
Critically ill infants admitted to an intensive care unit are at risk for high levels of morbidity and mortality. In the USA, approximately 400,000 newborns are admitted to a neonatal ICU annually, costing at least USD 26 billion and accounting for up to 50% of the total national pediatric health care expenditure. More...12 Oct 2021

High Cell-Free DNA Integrity Is a Biomarker for Poor Breast Cancer Survival
A team of Finnish researchers has refined a liquid biopsy analysis technique to act as a more specific biomarker in order to more accurately predict poor prognosis for patients with aggressive breast cancer. More...12 Oct 2021

Elevated Circulating Fatty Acid Synthase Is a Diagnostic Biomarker for Peripheral Artery Disease
Elevated levels of a soluble form of the enzyme fatty acid synthase (sFSA) in the blood have been linked to development of the severe vascular disorder peripheral artery disease (PAD). More...11 Oct 2021
In Other News
Meridian Launches New Air-Dryable qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
ALPK3 Truncating Variants Cause Autosomal Dominant Hypertrophic Cardiomyopathy
PCR Assay Detects and Differentiates Coccidioides Species
Next-Generation Multiomics Blood-Based Test for Pancreatic Cancer Could Become Powerful Tool for Early Diagnosis and Treatment
Liquid Biopsy Test Tracks Treatment-Based ctDNA Changes
New State-of-the-Art, Ultrasensitive Blood Test to Transform Detection of Brain Damage and Poor Prognosis After Head Injury
A Blood-Based Liquid Biopsy Combined with Machine Learning for Early Lung Cancer Diagnosis
Benign Hypertension-Causing Tumors Linked to Somatic Co-Driver Mutations
WHO Warning: Rapid Tests Misdiagnose Many Cases of P. falciparum Malaria in Africa
Next Generation Rapid Antibiotic Susceptibility Testing (AST) Platform Granted FDA Breakthrough Device Designation
IFN-γ Signature Distinguishes Pediatric Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS
Liquid Bioassay for Ultrasensitive Detection of Circulating HPV DNA
New Non-Invasive Blood Test for Colon Cancer Presented at 2021 AACC Annual Scientific Meeting
Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
Visby Medical Presents New Portable PCR COVID-19 Test Kit at 2021 AACC Annual Scientific Meeting & Clinical Lab Expo
Mammoth Biosciences Presents AACC 2021 Disruptive Technology Award Finalist CRISPR-Based Detection Platform
Hologic Displays Automated Solutions And Expansive Diagnostic Menu to Help Labs Grow at AACC 2021
Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021
Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021
Novel Tool Developed to Detect and Identify Pathogens
Placental MicroRNAs Diagnosis Pregnancy Progress and Fetal Distress
Thermo Fisher Presents Newest LC-MS/MS Instrumentation and Latest Innovations in Molecular Diagnostics
Clear Labs Introduces Clear Dx SARS-CoV-2 Solution That Addresses and Overcomes Traditional Barriers to NGS
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








